* IMSTAR *
1985 - IDF
Paris
www.imstar.fr Contract, Services
Key words: Microscopic imaging, Cell screening, Systems, Instruments, High throughput, Pathfinder
Mission: to provide third parties with complete vertical solutions for fully automated high-throughput cellular analysis, in the fields of genotoxicity and environmental toxicity, focused on compound screening, biomonitoring, cytopathology, and dedicated to research, diagnostic, staging and drug discovery
Clients: Research labs
info@imstar.fr
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Spin-off |
Managing Dir.: Soussaline (Françoise) [born 1945]
Sc.Dir.: Soussaline (Françoise)
Fin.Dir.:
BusDev:
Financers: privately owned | Turnover (M€) : 0.77 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Studies
Position : Subcontractor
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .10 | Research : publication in Mutagenesis with validation of the automated scoring for Micronucleus assay using IMSTAR Pathfinder technology on human lymphocytes | R&D | [23 years] |
| 2008 .05 | Partnering distribution agreement with Naturegene for China market | MKTG | [23 years] |
| 1997 .00 | Launch of Pathfinder, for automated digital imaging | MKTG | [12 years] |
| 1985 .09 | Company founded by Françoise Soussaline, as a spin-off from CEA | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
